Physician

Renee Louise Fischer, MD

According to 2025 Medicare claims, Renee Fischer, MD (NPI: 1982667226) practices internal medicine in the Charlottesville, VA market, with the plurality of this provider's patient population coming from Charlottesville City, VA. This provider's primary affiliated billing organization is CHARLOTTESVILLE INTERNAL MEDICINE, PLC (NPI: 1730807959; TIN: 541820164) and primary practice location at 22901-5708. Fischer is affiliated with the Sentara Accountable Care Organization, LLC (ACO ID: A4868), participating under the MSSP model.

Fischer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 598 traditional Medicare patients, billed 6,152 HCPCS/CPT codes, and received $291,485 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 8,678 prescription claims across 596 beneficiaries totaling $635,611 in drug costs, led by Eliquis (Apixaban). DME data shows 108 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $166,556 to $291,485. Similarly, Part D prescription costs have moved sharply higher in recent years, from $321,455 to $635,611. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $3,239 and ending at $19,813.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$146K$291K2015 Medicare payment: $166,556 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $157,204 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $160,165 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $166,030 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $128,899 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $137,013 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $192,095 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $215,446 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $288,353 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $291,485 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155324,346$166,556
20164865,212$157,204
20175126,122$160,165
20185215,659$166,030
20194783,171$128,899
20205263,353$137,013
20215734,229$192,095
20226104,631$215,446
20236055,126$288,353
20245986,152$291,485

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$318K$636K2015 Drug cost: $321,455 (USD; Tot_Drug_Cst)2016 Drug cost: $302,882 (USD; Tot_Drug_Cst)2017 Drug cost: $323,187 (USD; Tot_Drug_Cst)2018 Drug cost: $303,119 (USD; Tot_Drug_Cst)2019 Drug cost: $359,521 (USD; Tot_Drug_Cst)2020 Drug cost: $413,234 (USD; Tot_Drug_Cst)2021 Drug cost: $463,105 (USD; Tot_Drug_Cst)2022 Drug cost: $511,279 (USD; Tot_Drug_Cst)2023 Drug cost: $635,913 (USD; Tot_Drug_Cst)2024 Drug cost: $635,611 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154045,118$321,455
20164155,395$302,882
20174005,431$323,187
20184205,707$303,119
20194745,931$359,521
20204805,870$413,234
20214936,443$463,105
20225397,193$511,279
20235707,820$635,913
20245968,678$635,611

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$5.9K$12K2015 Medicare payment: $2,236 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $2,209 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $1,051 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $2,638 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $3,290 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $3,467 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $3,505 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $11,749 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $982 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $2,329 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201580167$2,236
201658153$2,209
201740118$1,051
201857190$2,638
201943162$3,290
202043162$3,467
202120107$3,505
202230126$11,749
20231680$982
202417108$2,329

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G0439Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit516516$125
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more5591,368$54
G0444Annual depression screening, 5 to 15 minutes514514$18
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's438810$11
36415Insertion of needle into vein for collection of blood sample5631,256$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban1398,999$170,671
OzempicSemaglutide1034,638$145,613
XareltoRivaroxaban171,530$26,744
JanuviaSitagliptin Phosphate161,440$25,852
FarxigaDapagliflozin Propanediol201,260$22,838

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateYN/R12$891
A4253Blood glucose test or reagent strips for home blood glucose monitor, per 50 stripsN1743$714
K0003Lightweight wheelchairYN/R21$490
E0431Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubingYN/R12$197
A4259Lancets, per box of 100NN/R20$38

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Renee Louise Fischer, MD?

Tedicare shows public-source Medicare data for Renee Louise Fischer, MD (NPI 1982667226), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Renee Louise Fischer, MD have ACO affiliation data?

Renee Louise Fischer, MD is shown with ACO affiliation data for Sentara Accountable Care Organization, LLC (MSSP, ACO ID A4868).

What billing organization is linked to Renee Louise Fischer, MD?

Renee Louise Fischer, MD is linked to CHARLOTTESVILLE INTERNAL MEDICINE, PLC (billing NPI 1730807959) in the available physician profile data.

Does Renee Louise Fischer, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.